Bennett WM - Search Results

1

Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.

Norman DJ, Shield CF 3rd, Barry J, Bennett WM, Henell K, Kimball J, Funnell B, Hubert B. Norman DJ, et al. Among authors: bennett wm. Am J Kidney Dis. 1988 Feb;11(2):107-10. doi: 10.1016/s0272-6386(88)80190-2. Am J Kidney Dis. 1988. PMID: 3277400 Clinical Trial.

2

Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990.

Norman DJ, Bennett WM, Wetzsteon PJ, Hefty T, Meyer MM, Tolzman D, Seely M, Millhollen M, Barry JM. Norman DJ, et al. Among authors: bennett wm. Clin Transpl. 1991:153-7. Clin Transpl. 1991. PMID: 1820113

3

OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses.

Norman DJ, Barry JM, Bennett WM, Munson JL, Meyer M, Henell K, Kimball J, Hubert B. Norman DJ, et al. Among authors: bennett wm. Transplant Proc. 1991 Feb;23(1 Pt 2):1052-4. Transplant Proc. 1991. PMID: 1846453 No abstract available.

4

The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.

Norman DJ, Barry JM, Bennett WM, Leone M, Henell K, Funnell B, Hubert B. Norman DJ, et al. Among authors: bennett wm. Am J Kidney Dis. 1988 Feb;11(2):90-3. doi: 10.1016/s0272-6386(88)80186-0. Am J Kidney Dis. 1988. PMID: 3124611

5

Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.

Norman DJ, Shield CF 3rd, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M. Norman DJ, et al. Among authors: bennett wm. Transplantation. 1988 Oct;46(4):523-9. doi: 10.1097/00007890-198810000-00011. Transplantation. 1988. PMID: 3140448

6

Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants.

Barry JM, Shively N, Hubert B, Hefty T, Norman DJ, Bennett WM. Barry JM, et al. Among authors: bennett wm. Transplantation. 1988 Feb;45(2):346-8. doi: 10.1097/00007890-198802000-00020. Transplantation. 1988. PMID: 3278427

7

A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation.

Norman DJ, Kimball JA, Bennett WM, Shihab F, Batiuk TD, Meyer MM, Barry JM. Norman DJ, et al. Among authors: bennett wm. Transpl Int. 1994 Aug;7(5):356-61. doi: 10.1007/BF00336712. Transpl Int. 1994. PMID: 7993573 Clinical Trial.

8

A case control study of renal transplantation in patients with type I diabetes.

Munson JL, Bennett WM, Barry JM, Norman DJ. Munson JL, et al. Among authors: bennett wm. Clin Transplant. 1992 Aug;6(4):306-11. Clin Transplant. 1992. PMID: 10147945 Clinical Trial.

9

HLA-identical sibling renal transplantation--a 21-yr single-center experience.

de Mattos AM, Bennett WM, Barry JM, Norman DJ. de Mattos AM, et al. Among authors: bennett wm. Clin Transplant. 1999 Apr;13(2):158-67. doi: 10.1034/j.1399-0012.1999.130202.x. Clin Transplant. 1999. PMID: 10202612

10

Renal transplantation across the ABO barrier using A2 kidneys.

Alkhunaizi AM, de Mattos AM, Barry JM, Bennett WM, Norman DJ. Alkhunaizi AM, et al. Among authors: bennett wm. Transplantation. 1999 May 27;67(10):1319-24. doi: 10.1097/00007890-199905270-00005. Transplantation. 1999. PMID: 10360584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters